Inform Diagnostics is one of the largest national pathology labs in the U.S. and offers services including gastrointestinal pathology, dermatopathology, urologic pathology and hematopathology. It provides services to about 1,300 clients who represent 2,700 physicians.
Fulgent said April 18 that the deal is expected to close in the second quarter of 2022. The acquisition would bolster Fulgent’s testing capabilities, sales force and managed care contracts and expand Fulgent’s footprint to labs in New York, Arizona, Massachusetts and Texas.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.